华尔街日报新闻文本数据简介
《华尔街日报》(The Wall Street Journal)是一家以财经报道为特色的综合性报纸,侧重金融、商业领域的报道,在国际上具有广泛影响力,日发行量达200万份。同时出版了亚洲版、欧洲版、网络版,每天的读者大概有2000多万人。《华尔街日报》新闻舆论通过尖利的笔锋净化着商业市场,正是它的舆论监督让商业公司不能为所欲为。
《华尔街日报》报导风格主要如下:
- 以严肃见长。报纸上绝大部分为文字报导,插图新闻很少,相比以活泼著称的《今日美国》形成鲜明对照。《华尔街日报》始终是美国最高端的报纸,其读者群的平均家庭年收入是15万美金。
- 以深度报导见长,对题材的选择也非常谨慎。该报的记者选题的平均周期为六个礼拜。1999年,美国《哥伦比亚新闻评论》评选“走向21世纪的美国21种最佳报纸”,《华尔街日报》名列第三,原因在于“其调查行报导所保持的高品质和挖掘精神”。到2004年底,《华尔街日报》的日均发行量约为180万份。
为支持相关研究,CnOpenData推出华尔街日报新闻文本数据,包含标题、副标题、所属板块、类别、作者、发布日期等字段。
时间区间
1997-2024
数据规模
字段展示
华尔街日报新闻文本数据字段表-英文 | 华尔街日报新闻文本数据字段表-中文 |
---|---|
ID | ID |
title | 标题 |
subHead | 副标题 |
section | 所属板块 |
category | 类别 |
content | 内容 |
author | 作者 |
date | 发布日期 |
timeTag | 具体更新时间 |
样本数据
ID | title | subHead | section | category | content | author | date | timeTag |
---|---|---|---|---|---|---|---|---|
ID | 标题 | 副标题 | 所属板块 | 类别 | 内容 | 作者 | 发布日期 | 具体更新时间 |
b508b4a3f75503c9a451420f658309b4 | Moderna Cuts Outlook Amid Covid-Vaccine Supply Hurdles | Health | Health | Moderna said a decline in demand for its Omicron-targeting Covid-19 doses also hit its performance in its latest quarter. Photo: Simon Simard for The Wall Street JournalModerna Inc.’s third-quarter revenue fell by nearly a third and the pharmaceutical company cut its outlook, saying as part of its earnings report that supply constraints for its Covid-19 vaccines might sap as much as $3 billion in sales this year.The Cambridge, Mass.-based company said Thursday that higher costs and a decline in demand for its original Covid-19 vaccine also hit its performance.Moderna, which three months ago said it projected $21 billion in product sales of its Spikevax vaccine for anticipated delivery this year, now expects between $18 billion and $19 billion. The company said short-term supply constraints will delay some sales into 2023.Advertisement - Scroll to Continue The choppy results came during a quarter of transition for Moderna. Demand for its original Covid-19 vaccine and booster shot dropped, while the company rolled out updated booster shots designed to better target Omicron subvariants of the coronavirus.Newsletter Sign-upThe 10-Point.A personal, guided tour to the best scoops and stories every day in The Wall Street Journal.PreviewSubscribeU.S. regulators cleared one of the updated boosters in late August, and uptake has been relatively slow. Moderna’s new booster shot was in short supply because a contract manufacturer had quality issues that held up the release of doses. At the same time, Moderna shifted to five-dose vials from 10-dose vials for packaging its vaccine.“We actually had to deal with a very complex third quarter from a manufacturing standpoint,” Moderna Chief Executive Stéphane Bancel said on a conference call with analysts. He said the company had “many lessons to be learned,” and is working to address the challenges.Moderna shares were off 2.5% at $144.89 at midday Thursday.For the third quarter, Moderna’s product sales declined 35% to $3.1 billion.The company’s cost of sales was $1.1 billion, representing 35% of total product sales in the quarter, rising from $722 million a year earlier. Costs rose partly because of a $333 million charge to write down inventory for vaccine doses that exceeded or were expected to exceed their approved shelf lives. This year, Moderna and other vaccine makers have had to discard unused doses as demand for the shots fell sharply.The new bivalent vaccine might be the first step in developing annual Covid shots, which could follow a similar process to the one used to update flu vaccines every year. Here’s what that process looks like, and why applying it to Covid-19 could be challenging. Illustration: Ryan TrefesModerna also booked expenses for unused manufacturing capacity, and some of its purchase commitments were canceled, the company said.Research-and-development expenses at Moderna rose 57% to $820 million, as the company is running several large clinical trials of experimental drugs and vaccines.Moderna is developing vaccines against seasonal influenza and respiratory syncytial virus, or RSV—bugs that are causing hospitalizations in the U.S. Moderna also is developing a combination vaccine designed to protect against Covid, flu and RSV in a single shot.The company also is developing a vaccine with potential to treat cancer, and which is being tested in combination with a Merck & Co. cancer drug in a clinical trial of patients with the skin cancer melanoma.Results of studies of some of these experimental vaccines are due out in the coming weeks and months.Overall for the quarter, the company said net income fell to $1 billion, or $2.53 a share, compared with $3.3 billion, or $7.70 a share, a year earlier. Analysts had expected $3.30 a share, according to FactSet.Revenue dropped to $3.4 billion, short of analyst estimates for $3.5 billion.Earlier this week, Pfizer Inc. raised its revenue outlook for the year but the company experienced a drop in third-quarter sales of its vaccine to $4.4 billion from nearly $13 billion a year earlier.Write to Peter Loftus at Peter.Loftus@wsj.com and Sabela Ojea at sabela.ojea@wsj.comHow the Biggest Companies Are PerformingWSJ coverage and analysis of the latest corporate earnings Salesforce Margins Rise Amid Cost Cuts Nvidia’s AI Surge Is Just Getting Started Walmart Lifts Outlook as Sales Rise Dick’s, Macy’s Flash Warning Signs on Consumer Housing Market Still Working in Home Depot’s Favor UPS Reduces 2023 Forecasts Apple Sales Slump, Services Unit Hits Record Disney Gets Iger’s Second Show on the RoadAdvertisement - Scroll to Continue | By Peter Loftus and Sabela Ojea | 2022/11/3 | Updated Nov. 3, 2022 4:19 pm ET | |
4c0625bc3093f492577adbab3ac03ac4 | Fed’s Hard Line on Interest Rates Fuels Bond Rout | Finance | Treasurys | Federal Reserve Chairman Jerome Powell’s comments are likely to make investors reconsider the recent stock rally, analysts said. Photo: ELIZABETH FRANTZ/REUTERSThe Federal Reserve’s signals of more interest-rate increases ahead rattled financial markets anew Thursday, sending stocks lower and driving bond yields back near multiyear highs.Thursday’s declines extended losses that began after Fed Chairman Jerome Powell’s Wednesday-afternoon warning that high inflation means it is still too soon to think about any pause in the central bank’s inflation-fighting campaign. His comments dashed Wall Street’s hopes for some relief after officials lifted the target fed-funds rate by 0.75 percentage points for the fourth straight meeting.Newsletter Sign-upMarketsGet email notifications when major financial-market and trading news breaks.PreviewSubscribeRising rates have hit investors hard, sending the S&P 500 down 22% so far this year and sparking a historic rout in bonds. The resulting surge in yields, which rise when bond prices fall, has sent shock waves through markets, lifting borrowing costs on everything from mortgages to corporate loans. The blow has fallen particularly hard on Wall Street’s more speculative bets, including shares of highflying technology companies.On Thursday, the stock market notched more losses, with the S&P 500 losing 1.1% and the tech-heavy Nasdaq Composite falling 1.7%. The benchmark 10-year Treasury yield finished at 4.123%, according to Tradeweb, up from 4.059% on Wednesday and back near its highest levels since 2008, unwinding some of a recent rally that had carried it below 4%.The two-year Treasury yield—even more sensitive to near-term Fed policy changes—finished Thursday at 4.699%, a new high since 2007.Advertisement - Scroll to Continue Normally the Federal Reserve makes a profit from its balance sheet, but with higher interest rates it is now in the red. WSJ explains how the Federal Reserve makes money, what it does with it, and what happens now.The market response “shows that Powell did a good job indicating the Fed remains adamantly focused on bringing inflation back into a more subdued range,” said Blair Shwedo, head of investment-grade bond trading at U.S. Bank. “He did a good job walking back any bullishness in risk assets.”Yields have marched higher for most of 2022, tracking the Fed’s most aggressive set of rate increases since the 1980s. At times, such as in mid-July or during parts of October, the rise has stalled as traders questioned whether falling inflation or an economic downturn could force the Fed to cut rates again sooner rather than later. Each time, signals from Mr. Powell and other Fed officials have driven yields back up.Rates have also been moving higher around the world. On Thursday, the Bank of England matched the Fed with its own 0.75-percentage-point rate increase, the U.K.’s biggest rate increase since 1989. Late last month, a same-sized move by the European Central Bank brought euro rates to their highest level in more than a decade.In the U.S., traders on Thursday extended bets that rates will stay higher for longer. Derivatives-market bets show that traders now think the Fed’s benchmark rate will rise above 5% next year. A month ago, bets suggested a peak closer to 4.5%. A long period of higher rates could jar markets, particularly tech stocks, where investors expect a large share of companies’ profits far in the future. “If the Fed’s rates go up, that directly translates into higher yields. Those higher yields are what we use to calculate present value for the stock market,” said Jurrien Timmer, director of global macro at Fidelity. Higher Treasury yields hurt stock valuations in part because they offer investors a much safer way to lock in positive returns.Still, many investors predict a recession is on the way, which could eventually lead the Fed to reverse course. The housing market—one of the fastest-growing parts of the economy in recent years—has abruptly slowed as mortgage costs soar. Profit growth is dimming for companies from Silicon Valley to Wall Street. A key bond-market indicator is flashing recession warnings. The two-year Treasury yield finished Thursday 0.576 percentage point higher than the 10-year yield, the biggest yield premium for the shorter-term bond since 1982. This reversal of the norm—known as a yield curve inversion—shows investors expect a downturn to eventually force rate cuts. Investors will get a fresh look at the economy’s prospects from Friday’s jobs report. Economists expect the Labor Department’s data to show the economy added 205,000 jobs in October, a strong pace by historical standards but slower than September’s.Some analysts said Mr. Powell’s comments are likely to make investors reconsider the hopes fueling the recent stock rally, which made October the Dow Jones Industrials’ best month since 1976. Similar bets that economic weakness might force the Fed to act less aggressively sparked a previous rally that peaked in August. “If you’re excited to put capital to work into year-end, it’s worth noting Powell said we have a ways to go multiple times,” Mike Zurfluh, a macroeconomic analyst at investment bank Evercore ISI, wrote in a note to clients.Write to Matt Grossman at matt.grossman@wsj.comInflation and the EconomyAnalysis from The Wall Street Journal, selected by the editors Demand for Workers Cools, but Remains Elevated Why Central Bankers Are Unsure Whether They’ve Raised Rates Enough Child-Care Prices Rising at Nearly Twice Inflation Rate Gasoline, Food Threaten to Nudge Inflation Up Cooler July Inflation Opens Door to Fed Pause Jobs Market Shows Signs of Gradual Cooling Soft Landing in Sight for U.S. Economy What to Know About InflationAdvertisement - Scroll to Continue | By Matt Grossman | 2022/11/3 | Updated Nov. 3, 2022 4:22 pm ET | |
8f9c018efab73ac608136810350cf168 | Teva Pharmaceutical to Replace CEO Kare Schultz | Business | Health | Kare Schultz said he wanted to make time for his family. Photo: Christopher Goodney/Bloomberg NewsTeva Pharmaceutical TEVA 0.72%increase; green up pointing triangle Industries Ltd. said it is looking for a new chief executive officer after Kare Schultz confirmed he will step down when his contract expires next year.Mr. Schultz said Thursday that he chose not to renew his contract, which expires in November 2023. “I’m here until then,” he said in an interview.Mr. Schultz said that for years he has wanted to retire at 62, a mandatory retirement age at a previous employer. He will turn 62 in May. His eldest daughter is due to give birth in the coming weeks, he said, making him a grandfather, and he wanted to make time for his family.Advertisement - Scroll to Continue “That combination is motivating me to want to stop,” he said.Mr. Schultz and Teva had suggested previously that he was unlikely to renew his contract. The Israeli news outlet Globes previously reported that Mr. Schultz’s contract wouldn’t be renewed. Teva is one of the world’s largest manufacturers of generic drugs. The board has begun a search for a new CEO, a Teva spokeswoman said.Mr. Schultz took the helm of the Israeli drugmaker in 2017, when Teva had falling profits, a large debt load and a declining share price.Under Mr. Schultz’s leadership, Teva has cut thousands of jobs and closed plants as it paid down debt. He pushed the company further into areas such as biologic drugs, injectables made from living cells, while introducing new products such as migraine treatment Ajovy.Teva has worked to resolve legal challenges including the company’s alleged role in the U.S. opioid epidemic. It recently said it reached a settlement agreement worth up to $4.25 billion to resolve thousands of lawsuits related to the opioid crisis.Shares of Teva were about $14 when Mr. Schultz became CEO, rose to as much as roughly $24 before declining, and closed Wednesday at $8.74. Shares were trading at $8.61 at the closing bell on Thursday.Mr. Schultz wants to stay engaged with the company including possibly serving on its board, the Teva spokeswoman said. Teva’s U.S. generics business remains challenged but its pipeline of drugs could fuel growth if they receive regulatory approval, analysts have said.Mr. Schultz joined Teva after serving as CEO of drugmaker Lundbeck A/S. He also worked at Novo Nordisk A/S, one of Denmark’s biggest companies.Write to Jared S. Hopkins at jared.hopkins@wsj.comAdvertisement - Scroll to Continue | By Jared S. Hopkins | 2022/11/3 | Nov. 3, 2022 4:24 pm ET | |
59f13dedb745b5015f376f0120c6a9c5 | Investors Rekindle Love Affair With Short-Term Success | Finance | STREETWISE | Interest rates are strongly encouraging investors to have a shorter-term outlook. Photo: Spencer Platt/Getty ImagesInvestors are focused on the short-term again, and it is pushing CEOs away from spending on major long-term projects. The cause? Mainly the Federal Reserve and its aggressive interest-rate rises.Put simply, why bet on risky ventures that might possibly pay off in 10 years when you can earn 4.5% on a totally safe one-year T-bill? Interest rates are strongly encouraging investors to have a shorter-term outlook.Investors lost their zeal for speculative super-long-term bets last year, and the stocks of lossmaking early-stage growth companies in fields such as online taxis, electric cars, instant groceries, space tourism and even internet dog walking crashed. Advertisement - Scroll to Continue Normally the Federal Reserve makes a profit from its balance sheet, but with higher interest rates it is now in the red. WSJ explains how the Federal Reserve makes money, what it does with it, and what happens now.This year, the malaise spread to the biggest growth stocks. Last week, shares in Meta Platforms, nee Facebook, plummeted 25% in a day after founder Mark Zuckerberg insisted he would press on with a moonshot-scale bet on developing virtual reality. Investors don’t want to finance long-term projects with returns that even Mr. Zuckerberg admits he has no way to forecast. In the new environment, investors would much rather see cold hard cash than throw money at leaps into the unknown. Companies are starting to understand the implications: If they want a healthy share price, focus on profits today. That matters both for investors and for the economy. When rates were at zero and the Fed was buying government bonds, investors felt they had to take more risk to earn a return. Companies could borrow for less than ever before and as memories of the 2008-09 global financial crisis faded, shareholders encouraged those with what were perceived as good ideas to spend big to try to make “moonshot” plans come good.Such bets are mostly history, because the Fed and other central banks have been frantically hiking rates to tackle runaway inflation. In just the past year, the real cost of 10-year borrowing has jumped from 1 percentage point below inflation to 1.5 points above. That’s a gigantic shift, by far the biggest since 2003, when the Treasury’s figures for Treasury inflation-protected securities start. ARK Innovation, perhaps the fund with the most exposure to companies chasing high-risk, high-reward, long-term ideas, has lost more than three-quarters of its value since its peak in February last year.Outside the world of wild bets on the far-distant future, capital projects with more predictable payoffs are still being funded—but CEOs say that may not last.Ryan Hammond, a U.S. equity strategist at Goldman Sachs, says this year the biggest cut in spending has been on buybacks as companies hoard cash, with capital expenditure, or capex, and research and development continuing to grow. Next year may be a different story, though, and he forecasts a sharp drop in the growth rate of capex.“When growth slows, usually investors reward those companies returning cash to shareholders,” he said. “There’s some skepticism about investing at a time when the economy is slowing, will the RoI return on investment reward the higher cost of capital?”The proportion of business leaders planning to increase capital spending is the lowest since 2013, aside from the pandemic, according to the New York Federal Reserve. The share planning to cut capex has doubled since February to 18%, although remains far below that reached in past recessions.Salman Ahmed, global head of macro at Fidelity International, says still-strong capex reflects past easy money. “It’s an indicator of last year’s frenzy and will go away,” he said. “This year’s leading indicators—IPOs and M&A have collapsed—I would think will show up in next year’s capex numbers.”Other forms of capex may be viewed more positively, and certainly companies are still spending, for now. The Philadelphia Fed survey of manufacturers last month found more firms planned to increase than reduce spending on energy-saving projects and non-computer equipment, even as more prepared to reduce than increase capex on buildings, computers and software. Government efforts to boost microchip production, protectionism on electric-car subsidies and corporate worries about supply chains should support domestic capex.SHARE YOUR THOUGHTSWhat are the implications of a return to short-term thinking on Wall Street? Join the conversation below.The embrace of short termism plays into the arguments of those who say too much short-term thinking has been a scourge on the economy. The reality, as I’ve written before, is that the markets have been happy to finance exceptionally long-term projects for a decade, throwing money at companies to launch lossmaking land grabs. That’s changing and the risk is that companies find it harder to justify worthwhile and profitable projects—good for the economy—even as renewed investment discipline puts an end to many wasteful white elephants.There are other factors at play besides the Fed. What’s likely to develop is a broader version of what happened to oil companies after their shares were crushed in 2016. After years of shareholders encouraging them to drill and expand, plunging crude prices switched the focus of investors to return on capital, and the engineers who led the industry lost their dominance to accountants.The interaction between fundamental forces and shareholder desires are still discouraging capex by major oil companies. Crude prices may be near $90 still and profits and share prices sky-high, but oil demand is expected to weaken in coming years and valuations are low.“The goal here is to sustain and grow the enterprise with the lowest capital possible,” Pierre Breber, chief financial officer of Chevron, told analysts last week. “And we are not really paid for growth by the market.”Wall Street has gone through the same switch it did with oil, suddenly applying a much higher cost of capital via lower share prices and higher borrowing costs. Moonshots are out, advertising and brand-building plans are being scaled back and capex for expansion will be next in line. The best hope for capex is for short-term projects where investors and finance departments can see the immediate payoffs in greater efficiencies.Expect stocks that give priority to stronger balance sheets and return spare cash to shareholders to beat those that keep plowing money back into growth. Only the firms with the strongest records of innovation, huge cash piles or ability to ignore investor pressure are likely to keep making wildly ambitious high-risk, high-reward bets.Write to James Mackintosh at james.mackintosh@wsj.comAdvertisement - Scroll to Continue | By James Mackintosh | 2022/11/3 | Updated Nov. 3, 2022 10:36 am ET | |
f25caedc345100aee3fcc9e88c5a61df | How Morticians Are Putting the Fun in Funerals | The A-hed | Morticians are finding ways to put the fun in funeral to get customers to think about their final farewells—and open their wallets—long before the end.At an industry convention in Baltimore last month, funeral directors were invited to a workshop on how to “build your preneed customer pipeline” and “generate warm leads.” Among the pro tips some have implemented: Dinners at cemeteries, so-called death cafes and burial-plot lotteries. Buy now, die later “I am selling a product nobody wants, but ultimately everybody has to have it,” said Brandon Patterson, one convention attendee.Mr. Patterson said 500 people showed up for a party at his Shreveport Funeral Home & Cremation Tribute Center in Louisiana in October. There was food, live music and a bouncy castle for kids. His staff raffled prizes including tumblers bearing the funeral home logo and tickets to a gospel-music concert. Grammy-nominated singer Major attended. Mr. Patterson said he sees such events as icebreakers into discussions on planning for one’s passage into the hereafter.“You have to find a way to make the conversation as pleasant as possible,” he said. A quarter or more of business at many funeral homes comes from services arranged while the customer was alive, according to Foresight Companies, a Phoenix-based consulting firm. Industry leaders see opportunities for growth. Most people in the U.S. haven’t planned their funerals, according to a March survey conducted by the National Funeral Directors Association. About 15% of people 40 and older said they had made arrangements in writing, but only a third of that group had started paying for them. Advertisement There are myriad ways for people to express themselves and show off their passions after death. At the Baltimore convention, companies displayed old-fashioned hearses and different styles of coffins. Some showcased see-through caskets and ones made of wicker. There were urns shaped like turtles and teddy bears. Some companies offered to turn your ashes into pebbles or use them to grow bonsai plants. The average cost of a funeral with viewing and burial is about $8,000—double the price from the early 1990s, according to the NFDA. That doesn’t include the cost of a monument or burial vault and plot. Customers, those in the industry say, can buy peace of mind in making their own pre-arrangements. “It takes the burden away from the people who survive you,” said Neil Fogarty, president of Dodds Memorials, a Xenia, Ohio-based company that makes cemetery monuments and markers.Those shopping for their future casket, funeral service, plot or tombstone have the option of paying today’s prices in full or paying installments into a trust or insurance plan.“People start planning and they realize, ‘Holy cow, there are so many decisions to be made,’” said Mr. Fogarty, who organized a three-day “Before I Die” festival in the Dayton, Ohio, area last weekend.The festival included a Day of the Dead-themed dinner at a cemetery, screenings of death-themed movies including “Coco” from Walt Disney Co.’s Pixar and a death cafe, where people could converse about mortality. Advertisement Gail Rubin, who has organized several ‘Before I Die’ festivals, celebrating Day of the Dead in the Albuquerque area in 2018. Photo: David Bleicher“We’re convincing people that just as talking about sex doesn’t make you pregnant, talking about death doesn’t make you dead,” said Gail Rubin, who spoke at the festival. She has hosted Before I Die festivals since 2017, and sells a do-it-yourself kit that includes a manual on how to organize a festival, a planning checklist and instructions on how to play the Newly-Dead Game, which involves couples answering questions about their partner’s final wishes.Bob Hoffman, a 76-year-old retired attorney, said that since attending his first Before I Die festival about four years ago, he and his wife decided to be cremated and paid $7,000 for a plot where their remains will be interred in a Washington, D.C., cemetery. He recently finalized what he called his “transition” playlist for his own memorial service, which includes Joni Mitchell’s “Woodstock” and Ben E. King’s “Stand by Me,” but he is still ironing out other details. He hopes to troubleshoot them at future festivals.“I’m going for more of the fun part of things,” Mr. Hoffman said. “Once you get into it, there is an endless amount of topics to look at.” Companies at the Baltimore convention showcased collections of handmade dresses for the deceased, as well as ways to turn your ashes into geodes.At Greenlawn Funeral Homes, Cremations & Cemeteries, in Bakersfield, Calif., dozens came to a recent “Chip and Learn” event where they aimed golf balls at a 5-gallon bucket for a chance to win 30% off a prepaid funeral package or burial plot. Greenlawn said it sold 20 “preneed” packages at a Before I Die event in 2019, during which attendees peered into an empty grave, poked the insides of caskets and explored workings of a crematory. Greenlawn has also hosted events at restaurants and wine bars for people to talk about their deaths and funerals. “At first some people were like, ‘This is disrespectful,’ but we’ve had a lot of engagement, a lot of positive reviews,” said Jim La Mar, Greenlawn’s president.Ashley Aley, 53, of Albuquerque, N.M., said she has decided on cremation and started downsizing her possessions and digital footprint since attending a death cafe at a local nursing home in 2018. “I think I was the youngest one there,” she said.Mountain View Funeral Home & Cemetery in Mesa, Ariz., is creating repeat customers by holding living funerals. At one gathering last year, held to coincide with the dearly not-yet-departed’s birthday, cans of soda and Bud Light filled an open casket and a funeral procession was organized, complete with a hearse. Wyndie Scott, a commercial props designer, said she organized the event for her husband because she wanted him to know how much he means to the people in his life.“I told him, I don’t know if I can hold a real funeral now. I don’t know if anything could be better than this,” she said. At the end of the event, Ms. Scott, who organized door-gifts for attendees, awarded two raffle winners a buy-one-get-one-free cremation deal from Mountain View. “One lady loved it and one friend thought it was the oddest, most uncomfortable thing,” she said.Katie Hill, owner of Mortuary Lift Company in Cedar Rapids, Iowa, demonstrated a lift’s capabilities at the funeral directors’ convention. The quirkier side of lifeThe A-Hed, named for a headline shaped like a capital A, has run on the front page of The Wall Street Journal since 1941.See more a-heds Three Men Battle the FBI Over Buried Civil War Gold. ‘Stuff Just Doesn’t Add Up.’ Obsessed Parents Overanalyze Photos of Their Kids at Camp Where Have All the Lindas Gone? People Are Hiring D-List Celebrities to Deliver Their Bad NewsAdvertisement | By Dominique Mosbergen / Photographs by Michelle Gustafson for The Wall Street Journal | 2022/11/3 | |||
5e6ccd3 |